Last reviewed · How we verify

NCT05389852: TwoDex

Analgesic Efficacy of Intravenous Dexmedetomidine for Supraclavicular Plexus Block

Completed Phase 4 Last updated 8 February 2024
What this trial tests

Phase 4 trial testing Dexmedetomidine in Surgery in 100 participants. Completed in 7 February 2024.

Timeline
1 January 2023
Primary endpoint
7 February 2024
7 February 2024

Quick facts

Lead sponsorHôpital du Valais
PhasePhase 4
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment100
Start date1 January 2023
Primary completion7 February 2024
Estimated completion7 February 2024
Sites1 location across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

Hôpital du Valais — full company profile →

Who can join

Adults 18 to 85, any sex, with Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of the study is to compare the duration of analgesia in patients undergoing forearm or hand surgery with a supraclavicular brachial plexus block, who receive either iv dexmedetomidine or placebo.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Dexmedetomidine

Trials testing the same drug.

Other recruiting trials for Surgery

Currently open trials in the same condition.

Other Hôpital du Valais trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05389852.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing